A new study finds that many of our genes, if disabled by a mutation, have a surprising ability to turn on backup genes to compensate for lost functions.
A “loopy” discovery in bacteria is raising fundamental questions about the makeup of our own genome. And revealing a potential wellspring of material for new genetic therapies.
Researchers at Columbia University College of Dental Medicine have engineered exosomes to carry CRISPR, significantly enhancing the delivery of genome editing components to specific cells and tissues.
Including BRCA1 testing with prenatal carrier screening could identify people at risk of breast, ovarian, and pancreatic cancer at a time when cancer screening could save their lives.
High-risk pregnant women being recruited for a clinical trial that aims to give parents detailed information about genetic abnormalities found in utero.
Two Columbia faculty are part of a 61-member international research team that discovered 25 epilepsy-causing mutations in new and previously identified genes.
Columbia's Wendy Chung, the original plaintiff in the case against Myriad Genetics, says the Supreme Court decision banning gene patents will open a new era of genomic medicine.
A study of children born with severe heart defects has found that at least 10 percent of cases stem from genetic mutations that occur spontaneously early in development.